Lung cancer – urgent action required to get back on track
Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK […]
Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK […]
Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN describes how some critical factors need to be taken into account when planning and organising PCN pharmacy […]
Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN explains the positive findings from a randomised controlled trial that evaluated the impact of a medicines’ optimisation […]
The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary […]
The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist […]
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people […]
Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed […]
Natural cannabidiol distillate is superior to synthetic CBD because of the benefits of the ‘entourage effect’, according to Moyra Cosgrove, Head of Nutrition for Naturecan, a company that […]
There is a growing body of evidence for the effectiveness of cannabidiol (CBD) in a number of health conditions. To find out more, IMI spoke to Moyra Cosgrove, […]
A global call to action issued by the International Pharmaceutical Federation (FIP) on 13th December 2021 sets out 18 urgent actions needed from academic institutions, professional organisations, policymakers […]
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]
A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
